T. Garrington et al., SUCCESSFUL MANAGEMENT WITH OCTREOTIDE OF A CHILD WITH L-ASPARAGINASE INDUCED HEMORRHAGIC-PANCREATITIS, Medical and pediatric oncology, 30(2), 1998, pp. 106-109
Background. Octreotide is a synthetic somatostatin analogue which has
been suggested for use in the management of acute pancreatitis. While
studies have looked at octreotide use in the setting of pancreatitis d
ue to chronic al cohol use or trauma, little is known of its role in m
anagement of drug induced acute pancreatitis tis, particularly in the
pediatric setting. Patients and Methods. We present a case of a 51/2-y
ear-old white female who developed severe, necrotizing, hemorrhagic pa
ncreatitis with pseudocyst formation secondary to L-asparaginase use a
s a part of her therapy for acute lymphoblastic leukemia (ALL). She wa
s managed initially with intravenous fluids, bowel rest, nasogastric s
uctioning, parenteral narcotices, and broad spectrum antibiotics. In-a
ddition, within 12 hours of admission to The Children's Hospital (TCH)
in Denver, Colorado, she began therapy with octreotide (5 micrograms/
kg/day IV divided b.i.d.). With this management, her pseudocyst decomp
ressed without need for surgical intervention, her pancreatitis fully
resolved, and she recovered full pancreatic function without any long-
term sequelae. Conclusion. Use of octreotide may have served a role in
limiting the severity of the disease process in this case. Further st
udies need to be done to verify its usefulness in this setting. (C) 19
98 Wiley-Liss, Inc.